Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Human Immunology
|
June 28, 2015
TGF-β1-induced regulatory T cells
Eva N Hadaschik, Alexander H Enk
International Journal of Dermatology
|
November 9, 2015
Altered expression of keratin 14 in lesional epidermis of autoimmune skin diseases
Xiaoying Wei, Katharina Fricker, Alexander H Enk, et al.
Acta Dermato-Venereologica
|
February 23, 2017
Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab
Jochen H Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica
|
September 30, 2021
Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists
Jochen H O Hoffmann, Christian Knoop, Alexander Enk, et al.
Acta Dermato-Venereologica
|
October 18, 2012
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events
Vera Seidling, Jochen H O Hoffmann, Alexander H Enk, et al.
Dermatologic Therapy
|
August 24, 2016
Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid
Roland Schneiderbauer, Stefanie Martinache, Monika Engstner, et al.
Journal of Dermatological Science
|
October 13, 2014
Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patients
Jochen H O Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica
|
April 27, 2021
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles
Jochen H O Hoffmann, Christian Knoop, Knut Schäkel, et al.
The Journal of Dermatology
|
January 20, 2021
Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients
Jochen H O Hoffmann, Christian Knoop, Kunt Schäkel, et al.
Experimental Dermatology
|
June 17, 2016
Interindividual variation of NETosis in healthy donors: introduction and application of a refined method for extracellular trap quantification
Jochen H O Hoffmann, Knut Schaekel, Maria R Gaiser, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Human Immunology
|
June 28, 2015
TGF-β1-induced regulatory T cells
Eva N Hadaschik, Alexander H Enk
International Journal of Dermatology
|
November 9, 2015
Altered expression of keratin 14 in lesional epidermis of autoimmune skin diseases
Xiaoying Wei, Katharina Fricker, Alexander H Enk, et al.
Acta Dermato-Venereologica
|
February 23, 2017
Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab
Jochen H Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica
|
September 30, 2021
Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists
Jochen H O Hoffmann, Christian Knoop, Alexander Enk, et al.
Acta Dermato-Venereologica
|
October 18, 2012
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events
Vera Seidling, Jochen H O Hoffmann, Alexander H Enk, et al.
Dermatologic Therapy
|
August 24, 2016
Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid
Roland Schneiderbauer, Stefanie Martinache, Monika Engstner, et al.
Journal of Dermatological Science
|
October 13, 2014
Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patients
Jochen H O Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica
|
April 27, 2021
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles
Jochen H O Hoffmann, Christian Knoop, Knut Schäkel, et al.
The Journal of Dermatology
|
January 20, 2021
Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients
Jochen H O Hoffmann, Christian Knoop, Kunt Schäkel, et al.
Experimental Dermatology
|
June 17, 2016
Interindividual variation of NETosis in healthy donors: introduction and application of a refined method for extracellular trap quantification
Jochen H O Hoffmann, Knut Schaekel, Maria R Gaiser, et al.
Page
of 2